Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Nature

• Publication date

  2006-12-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature05349PMID 17151667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain tumour stem cells

  2006cited by this paper
• TGF-beta, neuronal stem cells and glioblastoma.

  2005cited by this paper
• TGF-β, Neuronal Stem Cells and Glioblastoma

  2005cited by this paper
• Neural stem cells and neurospheres—re-evaluating the relationship

  2005cited by this paper
• Tumour stem cells and drug resistance

  2005cited by this paper
• Radial glia cells are candidate stem cells of ependymoma.

  2005cited by this paper
• Bone Morphogenetic Proteins

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Stem cell origin of cancer and differentiation therapy.

  2004cited by this paper
• Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma

  2004cited by this paper
• Applying the principles of stem-cell biology to cancer

  2003cited by this paper
• BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect

  2003cited by this paper
• BMPs signal alternately through a SMAD or FRAP–STAT pathway to regulate fate choice in CNS stem cells

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Cancerous stem cells can arise from pediatric brain tumors

  2003cited by this paper
• Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro

  2002cited by this paper
• The control of neural stem cells by morphogenic signals.

  2002cited by this paper
• Stem cells, cancer, and cancer stem cells

  2001cited by this paper
• Noggin antagonizes BMP signaling to create a niche for adult neurogenesis.

  2000cited by this paper
• Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma.

  2000cited by this paper
• Expression of TGF‐β isoforms, TGF‐β receptors, and SMAD molecules at different stages of human glioma

  2000cited by this paper
• Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation.

  1999cited by this paper
• Bone morphogenetic proteins‐2 and ‐4 attenuate apoptosis in a cerebellar primitive neuroectodermal tumor cell line

  1999cited by this paper
• Neuronal Differentiation of Precursors in the Neocortical Ventricular Zone Is Triggered by BMP

  1998cited by this paper
• Survival and functional status after resection of recurrent glioblastoma multiforme.

  1998cited by this paper
• Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development.

  1997cited by this paper
• Alternative Neural Crest Cell Fates Are Instructively Promoted by TGFβ Superfamily Members

  1996cited by this paper
• Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell.

  1996cited by this paper
• Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members.

  1996cited by this paper
• Multipotent CNS Stem Cells Are Present in the Adult Mammalian Spinal Cord and Ventricular Neuroaxis

  1996cited by this paper
• A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

  1994cited by this paper
• Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt.

  1990cited by this paper
• 0163-769X/03/$20.00/0 Endocrine Reviews 24(2):218–235 Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/er.2002-0023 Bone Morphogenetic Proteins, Their Antagonists, and the Skeleton

  year unknowncited by this paper

• Hemp-Derived Extracellular Vesicles: A Novel Frontier in Nanomedicine and Therapeutics.

  2026cites this paper
• Investigating the therapeutic effect of metformin on melanoma cancer stem cells using optical microscopy.

  2026cites this paper
• A Versatile Multidrug Coloaded Nanoplatform Integrating Photothermal-Differentiation-Chemotherapy for Breast Cancer Stemness Inhibition.

  2026cites this paper
• SHH pathway inhibition and astrocyte co-culture induce distinct responses in glioblastoma and cancer stem cells

  2026cites this paper
• SHH Pathway Inhibition and Astrocyte Co-culture Induce Distinct Responses in Glioblastoma and Cancer Stem Cells

  2025cites this paper
• Gene and RNA Editing: Revolutionary Approaches to Treating Diseases

  2025cites this paper
• Regenerative Glycopeptide Scaffolds Enhance BMP-4 Activity To Treat Pediatric Glioma

  2025cites this paper
• Vortioxetine: A Potential Drug for Repurposing for Glioblastoma Treatment via a Microsphere Local Delivery System

  2025cites this paper
• Correlation Between Preoperative Tumor Volume and Postoperative Neurological Deficit in Brain Tumor Resections

  2025cites this paper
• Virtual Clinical Trials of BMP4 Differentiation Therapy: Digital Twins to Aid Successful Glioblastoma Trial Design

  2025cites this paper
• Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma.

  2025cites this paper
• Predictive molecular biomarkers of radiosensitivity in adult glioma: a narrative review

  2025cites this paper
• Brain microenvironment orchestrates highly aggressive tumor variants: current trends and therapeutic approaches

  2025cites this paper
• New insights into Gremlin-1: A tumour microenvironment landscape re-engineer and potential therapeutic target.

  2025cites this paper
• BMP signalling in colorectal cancer: losing the yin to WNTs yang

  2025cites this paper
• p21-Dependent Senescence Induction by BMP4 Renders Glioblastoma Cells Vulnerable to Senolytics

  2025cites this paper
• Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies

  2025cites this paper
• A Comprehensive Review Exploring the Role of Bone Morphogenetic Proteins [BMP]: Biological Mechanisms

  2025cites this paper
• Designing polyphosphazene derivatives for gene delivery in glioblastoma treatment

  2025cites this paper
• Endothelin Signaling via EDNRB receptor Reduces Proliferation and Promotes Proneural-to-Mesenchymal Transition in Gliomas

  2025cites this paper
• CGF-Conditioned Medium Modulates Astrocytic Differentiation and Invasiveness in U87MG Glioblastoma Cells

  2025cites this paper
• TurboID‐Mediated Profiling of Glioblastoma‐Derived Extracellular Vesicle Cargo Proteins

  2025cites this paper
• A Review of Therapeutic Agents Given by Convection-Enhanced Delivery for Adult Glioblastoma

  2024cites this paper
• Glioblastoma: A molecular insight into current discoveries and treatment directions

  2024cites this paper
• BMP4 and Temozolomide Synergize in the Majority of Patient-Derived Glioblastoma Cultures

  2024cites this paper
• Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?

  2024cites this paper
• Double‐Layered Hollow Mesoporous Cuprous Oxide Nanoparticles for Double Drug Sequential Therapy of Tumors

  2024cites this paper
• Glioma Stem Cells as Promoter of Glioma Progression: A Systematic Review of Molecular Pathways and Targeted Therapies

  2024cites this paper
• Expression of calpastatin hcast 3-25 and activity of the calpain/calpastatin system in human glioblastoma stem cells: possible involvement of hcast 3-25 in cell differentiation

  2024cites this paper
• Advances in ovarian tumor stem cells and therapy

  2024cites this paper
• Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma

  2024cites this paper
• Acid-sensing ion channel 3 is a new potential therapeutic target for the control of glioblastoma cancer stem cells growth

  2024cites this paper
• Therapeutic potential and impact of nanoengineered patient‐derived mesenchymal stem cells in a murine resection and recurrence model of human glioblastoma

  2024influential citation
• The hidden architects of glioblastoma multiforme: Glioma stem cells

  2024cites this paper
• The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human glioblastoma cells

  2024cites this paper
• Emergence of the cell-matrix adhesion element ILK as a player in glioblastoma cell plasticity.

  2024cites this paper
• An ILK/STAT3 pathway controls glioblastoma stem cell plasticity.

  2024cites this paper
• Mesenchymal Stem Cells in Cancer Therapy.

  2024cites this paper
• Tools to study neural and glioma stem cell quiescence.

  2024cites this paper
• TGFβ family signaling in human stem cell self-renewal and differentiation

  2024cites this paper
• The effects of BMP2 and the mechanisms involved in the invasion and angiogenesis of IDH1 mutant glioma cells

  2024cites this paper
• Bone Morphogenetic Protein Signaling Agonist SB4 (BMPSB4) Inhibits Corticotroph Pituitary Neuroendocrine Tumors by Activation of Autophagy via a BMP4/SMADs-Dependent Pathway.

  2024cites this paper
• The TGF-β Family in Glioblastoma

  2024influential citation
• Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells

  2023cites this paper
• Engineering Adenoviral Vectors with Improved GBM Selectivity

  2023cites this paper
• Amplified Ferroptosis and Apoptosis Facilitated by Differentiation Therapy Efficiently Suppress the Progression of Osteosarcoma.

  2023cites this paper
• Redox Homeostasis and Beyond: The Role of Wild-Type Isocitrate Dehydrogenases for the Pathogenesis of Glioblastoma

  2023cites this paper
• Identification of glioblastoma stem cell-associated lncRNAs using single-cell RNA sequencing datasets

  2023cites this paper
• Acetylation and deacetylation of histone in adipocyte differentiation and the potential significance in cancer

  2023cites this paper
• Identification of genes with oscillatory expression in glioblastoma: the paradigm of SOX2

  2023cites this paper
• BMP signaling in cancer stemness and differentiation

  2023cites this paper
• Systems Medicine for Precise Targeting of Glioblastoma

  2023cites this paper
• The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities

  2023cites this paper
• Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations

  2023cites this paper
• Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial

  2023influential citation
• Cancer Stem Cells and Their Therapeutic Usage.

  2023cites this paper
• An immune and epithelial–mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas

  2023cites this paper
• Identification of glioblastoma stem cell-associated lncRNAs using single-cell RNA-sequencing datasets

  2023influential citation
• ZNF117 regulates glioblastoma stem cell differentiation towards oligodendroglial lineage

  2022cites this paper
• Lumiflavin Reduces Cisplatin Resistance in Cancer Stem-Like Cells of OVCAR-3 Cell Line by Inducing Differentiation

  2022cites this paper
• Inhibiting ALK2/ALK3 Signaling to Differentiate and Chemo-Sensitize Medulloblastoma

  2022cites this paper
• Growth factor independence underpins a paroxysmal, aggressive Wnt5aHigh/EphA2Low phenotype in glioblastoma stem cells, conducive to experimental combinatorial therapy

  2022cites this paper
• Endocannabinoid signaling in glioma

  2022cites this paper
• Regional Development of Glioblastoma: The Anatomical Conundrum of Cancer Biology and Its Surgical Implication

  2022cites this paper
• KRAB-ZFPs and cancer stem cells identity

  2022cites this paper
• Bone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years

  2022cites this paper
• ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance

  2022cites this paper
• Bone morphogenetic protein receptor inhibitors suppress the growth of glioblastoma cells

  2022cites this paper
• Canonical BMP2/4 signaling degrades SOX2 in glioblastoma propagating cells

  2022cites this paper
• Challenges in glioblastoma research: focus on the tumor microenvironment.

  2022cites this paper
• Bone marrow-derived mesenchymal stem cells expressing BMP2 suppress glioma stem cell growth and stemness through Bcl-2/Bax signaling

  2022cites this paper
• Aptamer-Based Analysis and Manipulation of the Protein Activity in Living Cells.

  2022cites this paper
• State-of-the-art of the Bone Morphogenetic Protein research field: 13th International BMP Conference, Dubrovnik 2022

  2022cites this paper
• Lrig1 regulates the balance between proliferation and quiescence in glioblastoma stem cells

  2022cites this paper
• Glioma stem cells and neural stem cells respond differently to BMP4 signaling

  2022cites this paper
• The Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical Opportunities

  2022cites this paper
• The role of zinc finger E-box-binding homeoboxin the prognosis of Glioblastoma: A review

  2022cites this paper
• Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma

  2022cites this paper
• Nonviral nanoparticle gene delivery into the CNS for neurological disorders and brain cancer applications.

  2022cites this paper
• CHRDL1 Regulates Stemness in Glioma Stem-like Cells

  2022cites this paper
• Signaling pathways governing glioma cancer stem cells behavior.

  2022cites this paper
• Obstacles to Glioblastoma Treatment Two Decades after Temozolomide

  2022cites this paper
• Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity

  2022cites this paper
• Disruption of β-catenin-mediated negative feedback reinforces cAMP-induced neuronal differentiation in glioma stem cells

  2022cites this paper
• Ion Channel Drugs Suppress Cancer Phenotype in NG108-15 and U87 Cells: Toward Novel Electroceuticals for Glioblastoma

  2022cites this paper
• A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy

  2022cites this paper
• Human Platelet Lysate Induces Antiviral Responses against Parechovirus A3

  2022cites this paper
• Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers

  2022cites this paper
• The Role of Tumor Microenvironment in Regulating the Plasticity of Osteosarcoma Cells

  2022cites this paper
• Netrin-1 functions as a suppressor of bone morphogenetic protein (BMP) signaling

  2021cites this paper
• Polymer-Based Protein Delivery Systems for Loco-Regional Administration

  2021cites this paper
• DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem Cells

  2021cites this paper
• The white matter is a pro-differentiative niche for glioblastoma

  2021cites this paper
• γ-secretase inhibitors, DAPT and RO4929097, promote the migration of Human Glioma Cells via Smad5-downregulated E-cadherin Expression

  2021cites this paper
• Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives

  2021cites this paper
• Stem cells as therapeutic targets in colorectal cancer.

  2021cites this paper
• LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes

  2021cites this paper
• A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells

  2021cites this paper
• Diffuse Glioma Heterogeneity and Its Therapeutic Implications.

  2021cites this paper
• Glioma stem cells, plasticity, and potential therapeutic vulnerabilities

  2021cites this paper